Literature DB >> 5073307

Plasma and urinary levels of adriamycin in man.

R Rosso, C Ravazzoni, M Esposito, R Sala, L Santi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5073307     DOI： 10.1016/0014-2964(72)90132-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  10 in total

1.  Factors causing dose variability in drug administration.

Authors:  R Demicheli; A Jirillo; G Bonciarelli; F Lonardi; M Pradella; M Balli
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Preoperative transcatheter arterial chemo-embolization for locally advanced breast cancer. Application of new thrombotic materials.

Authors:  A Sugitachi; Y Takatsuka; I Sakamoto
Journal:  Jpn J Surg       Date:  1983-09

3.  Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia.

Authors:  H D Preisler; T Gessner; N Azarnia; W Bolanowska; J Epstein; A P Early; P D'Arrigo; R Vogler; L Winton; P Chervenik
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

4.  Preoperative one-shot intra-arterial infusion chemotherapy for bladder cancer.

Authors:  H Kakizaki; H Suzuki; Y Kubota; K Numasawa; K Suzuki
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  The persistence of adriamycin in man and rat.

Authors:  P M Wilkinson; G E Mawer
Journal:  Br J Clin Pharmacol       Date:  1974-06       Impact factor: 4.335

6.  Comparative metabolism and excretion of adriamycin in man, monkey, and rat.

Authors:  P M Wilkinson; M Israel; W J Pegg; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

7.  Time dependency of adriamycin and adriamycinol kinetics.

Authors:  P Gil; R Favre; A Durand; A Iliadis; J P Cano; Y Carcassonne
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

8.  [The pharmacokinetics of adriamycin and adriamycin-metabolites (author's transl)].

Authors:  G Ehninger; H J Stocker; B Proksch; K Wilms
Journal:  Klin Wochenschr       Date:  1980-09-15

9.  Effect of adriamycin on CFUGM at plasma concentrations found following therapeutic infusions.

Authors:  R Bailey-Wood; C M Dallimore; J A Whittaker
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

10.  Distribution of 4'epi-doxorubicin in human tissues.

Authors:  C Italia; L Paglia; A Trabattoni; S Luchini; F Villas; L Beretta; G Marelli; N Natale
Journal:  Br J Cancer       Date:  1983-04       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.